Atlas FDA

INTERSTIM THERAPY FOR URINARY CONTROL

FDA premarket approval P970004/S024 · decided 2003-04-01

Approval details

PMA number
P970004
Supplement
S024
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
INTERSTIM THERAPY FOR URINARY CONTROL
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2003-03-07
Decision date
2003-04-01
Days to decision
25 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
APPROVAL TO LIMIT USE OF THE MODEL 8870 APPLICATION CARD TO ONLY THE INTERSTIM AND ENTERRA APPLICATIONS BY MODIFYING THE DESKTOP SOFTWARE, TO REMOVE THE MODEL 8529 MAGNET USED WITH THE SYNCHROMED DRUG PUMP APPLICATION FROM THE PROGRAMMING UNIT, AND TO MODIFY THE LABELING TO REFLECT THESE CHANGES.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23